已发表论文

家族性结节性硬化症综合征致病基因的初步筛选

 

Authors Wang Y, Hu S, Tan X, Sang Q, Shi P, Wang C, Sang D

Received 5 February 2022

Accepted for publication 16 May 2022

Published 26 May 2022 Volume 2022:15 Pages 5247—5252

DOI https://doi.org/10.2147/IJGM.S359702

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Scott Fraser

Purpose: The aim of this study was to screen the possible pathogenic genes of one family with tuberous sclerosis complexes (TSCs).
Patients and Methods: All family members were examined through detailed clinical evaluations, auxiliary examinations and CT. Then, we selected five members from this TSC family as the test samples. They were analysed by a new exon group sequencing method. Single nucleotide polymorphisms (SNPs) were screened by using databases, such as dbSNP and HAPMAP, and then the candidate genes were selected. Genes were analysed, and finally, the most likely mutation sites were screened. The results were examined by Sanger sequencing.
Results: In this TSC family, we identified c.913+2T>G, a splicing site mutation in the 9th intron region of TSC1. Family members without TSC did not have this mutation.
Conclusion: The mutations in the intron regions cannot be ruled out as a pathogenic factor for TSC.
Keywords: pathogenic genes, tuberous sclerosis complex, whole exon sequencing, intron mutation